Myvajra Tablets contain two active substances: Emtricitabine and Tenofovir disoproxil fumarate.
These medications are part of the standard combination therapy for HIV, known as antiretroviral therapy (ART).
ART is a combination drug regimen commonly used for the effective treatment of HIV-1 infection.
Uses:
Myvajra Tablet is used to treat HIV-1 infection.
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.
Therapeutic Effects:
Inhibits HIV replication, reducing viral load.
Improves immune function.
Slows the progression of HIV disease.
Helps control the virus, maintain a low viral load, and improve overall health outcomes in individuals with HIV.
Interaction with Other Drugs:
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Myvajra Tablet, reducing effectiveness or causing undesirable side effects.
Storage:
Store at a temperature between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
Do not freeze.
Keep in original packaging.
Keep away from children and pets.
How to Consume:
Follow your healthcare provider's instructions regarding dosage, frequency, and duration.
Take with or without food, swallowing the tablets or capsules with water.
Adhere to the prescribed dosing schedule; do not alter the dosage without consulting your healthcare provider.
Safety Advices:
Pregnancy: consult with your healthcare provider before taking Myvajra Tablet.
Breastfeeding: Myvajra Tablet is excreted into human breast milk, but the potential risks to the infant are not well established. Consult a doctor before taking it.
Lungs: consult a healthcare provider for a thorough evaluation before taking Myvajra Tablet if you have a history of lung disease or are experiencing respiratory symptoms.
Liver: the safety of Myvajra Tablet in individuals with liver disease may depend on the specific type and severity of liver disease and other factors. Consult with a healthcare provider.
Alcohol: avoid excessive alcohol consumption while taking Myvajra Tablet.
Driving: avoid driving or operating heavy machinery if you experience side effects such as dizziness, drowsiness, or fatigue.
Side Effects:
Serious: kidney problems or renal toxicity, decreased bone mineral density or bone loss, lactic acidosis, hepatic steatosis, immune reconstitution syndrome.
Pregnancy and breastfeeding require individual evaluation and consultation with a doctor to weigh the benefits against potential risks.
Use cautiously in individuals with pre-existing conditions such as liver disease, kidney disease, or bone disorders.
Close monitoring and appropriate management are necessary in these cases.
FAQs:
Can Myvajra Tablet be taken with other antiretroviral medications?
Myvajra Tablet is often combined with other antiretroviral medications as part of a multidrug regimen for treating HIV infection. The specific combination of medications will depend on individual health status, treatment history, and potential drug interactions.
Can Myvajra Tablet be safely used by older adults?
Myvajra Tablet can be used in older adults. Still, dosage adjustments or additional monitoring may be necessary, as age-related changes in kidney and liver function can affect medication clearance. It is important to discuss individual health status and any concerns with a healthcare provider.
Can Myvajra Tablet be used in individuals with pre-existing bone conditions?
Individuals with pre-existing bone conditions, such as osteoporosis or osteopenia, may require careful monitoring and management when using Myvajra Tablet. It is important to discuss any underlying bone conditions with your healthcare provider to ensure appropriate bone health monitoring and potential supplementation.
Can Myvajra Tablet prevent all forms of HIV transmission?
Myvajra Tablet, when used as PrEP, significantly reduces the risk of HIV transmission through sexual activity or injection drug use. However, they do not provide 100% protection against HIV, and it is important to continue practicing safe sex and taking other preventive measures.
Can Myvajra Tablet cause lactic acidosis?
Although rare, Myvajra Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the accumulation of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.
Are any specific tests or monitoring required for bone health while taking Myvajra Tablet?
Monitoring of bone mineral density may be recommended for individuals on long-term treatment with Tenofovir disoproxil fumarate. Your healthcare provider may request bone density scans or blood tests to assess bone health and determine if any interventions or additional treatments are necessary.
Can Myvajra Tablet be used in individuals with liver or kidney disease?
Myvajra Tablets should be used cautiously in individuals with liver or kidney impairment. Dose adjustments or alternative treatment options may be necessary.
Fact Box:
Molecule name: Emtricitabine and Tenofovir disoproxil fumarate.
